JP2003189884A - 新規ユビキチン特異プロテアーゼ - Google Patents

新規ユビキチン特異プロテアーゼ

Info

Publication number
JP2003189884A
JP2003189884A JP2002287925A JP2002287925A JP2003189884A JP 2003189884 A JP2003189884 A JP 2003189884A JP 2002287925 A JP2002287925 A JP 2002287925A JP 2002287925 A JP2002287925 A JP 2002287925A JP 2003189884 A JP2003189884 A JP 2003189884A
Authority
JP
Japan
Prior art keywords
polypeptide
ser
leu
polynucleotide
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002287925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003189884A5 (enExample
Inventor
Hiroshi Yokota
博 横田
Kazunori Sato
一紀 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP2002287925A priority Critical patent/JP2003189884A/ja
Publication of JP2003189884A publication Critical patent/JP2003189884A/ja
Publication of JP2003189884A5 publication Critical patent/JP2003189884A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP2002287925A 2001-09-28 2002-09-30 新規ユビキチン特異プロテアーゼ Pending JP2003189884A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002287925A JP2003189884A (ja) 2001-09-28 2002-09-30 新規ユビキチン特異プロテアーゼ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-301580 2001-09-28
JP2001301580 2001-09-28
JP2002287925A JP2003189884A (ja) 2001-09-28 2002-09-30 新規ユビキチン特異プロテアーゼ

Publications (2)

Publication Number Publication Date
JP2003189884A true JP2003189884A (ja) 2003-07-08
JP2003189884A5 JP2003189884A5 (enExample) 2005-10-27

Family

ID=27615206

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002287925A Pending JP2003189884A (ja) 2001-09-28 2002-09-30 新規ユビキチン特異プロテアーゼ

Country Status (1)

Country Link
JP (1) JP2003189884A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1540015A4 (en) * 2002-08-30 2006-11-29 Rigel Pharmaceuticals Inc ASSAYS AND COMPOSITIONS FOR IDENTIFYING THE ACTIVITY OF DEUBIQUITINATING AGENTS MODULATING AGENTS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1540015A4 (en) * 2002-08-30 2006-11-29 Rigel Pharmaceuticals Inc ASSAYS AND COMPOSITIONS FOR IDENTIFYING THE ACTIVITY OF DEUBIQUITINATING AGENTS MODULATING AGENTS

Similar Documents

Publication Publication Date Title
US5955306A (en) Genes encoding proteins that interact with the tub protein
JPH10501135A (ja) 免疫抑制剤標的蛋白質
JP2007289196A (ja) 癌組織でディファレンシャルに発現される核酸配列
JP4383170B2 (ja) ヒストン脱アセチル化酵素９
JP2002525058A (ja) プロテインキナーゼｋｉａａ０５５１の薬剤としての使用
JPH1175873A (ja) 新規化合物
US20070117138A1 (en) Splice variant cannabinoid receptor (cb1b)
CA2281674A1 (en) Parg, a gtpase activating protein which interacts with ptpl1
US7193053B2 (en) Hypoxia-inducible factor 1alpha variants and methods of use
CA2391594A1 (en) Trefoil domain-containing polynucleotides, polypeptides, and antibodies
JP2003517821A (ja) ２７８６、ヒトアミノペプチダーゼ
US20040072268A1 (en) Methods for regulating BRCA1-BRCA2-containing complex activity
JP2003210183A (ja) ヒトＩκＢ−β
JP4232423B2 (ja) 新規ユビキチン特異プロテアーゼ
JP2002517998A (ja) ｐ２７（ＫＩＰ１）のＦＫＢＰ−１２との相互作用
JP2002523045A (ja) ヒトｒｎａ関連タンパク質
US6180384B1 (en) Compounds
WO2000079267A2 (en) Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer
JP2003189883A (ja) 新規ユビキチン特異プロテアーゼ
US20040171105A1 (en) Compositions and methods for cleaving IAP
JP2002186492A (ja) ヒトｒｃｅ１
US20060110769A1 (en) Regulation of novel human prolyl 4-hydroxylases
JPWO2004019983A1 (ja) 糖代謝関連遺伝子の転写因子の分解方法、分解阻害方法および分解阻害剤
JP4634302B2 (ja) テトラヒドロ葉酸合成酵素遺伝子
WO2009009773A1 (en) Use of otubain enzyme to cleave lysine-48-linked polyubiquitin

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050906

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080930

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090217